Next Generation Sequencing (NGS) Market: Insights, Key Players, and...

Next Generation Sequencing (NGS) Market: Insights, Key Players, and Growth Analysis 2024–2032

Posted 2025-03-20 20:17:16

The Next Generation Sequencing (NGS) Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2031. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market

Which are the top companies operating in the Next Generation Sequencing (NGS) Market?

The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market's extension. This Global Next Generation Sequencing (NGS) Market report provides the information of the Top Companies in Next Generation Sequencing (NGS) Market in the market their business strategy, financial situation etc.

Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Charles River Laboratories, Revvity, Promega Corporation., Agilent Technologies, Inc., Takara Bio Inc., Eurofins Scientific, Hamilton Company, BGI, Azenta US, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., PacBio., Macrogen, Inc., Gilson Incorporated, New England Biolabs, Oxford Nanopore Technologies plc., LGC Biosearch Technologies, PCR Biosystems, ACT Genomics, Quantabio, DNASTAR, and NimaGen. among others

Report Scope and Market Segmentation

Which are the driving factors of the Next Generation Sequencing (NGS) Market?

The driving factors of the Next Generation Sequencing (NGS) Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.

Next Generation Sequencing (NGS) Market - Competitive and Segmentation Analysis:

**Segments**

- Based on product and services, the next-generation sequencing market can be segmented into pre-sequencing products and services, NGS platforms, consumables, and services for platforms. The NGS platforms segment includes instruments, reagents, and consumables. The pre-sequencing products and services segment is expected to witness significant growth due to the increasing demand for sample preparation, library preparation, and target enrichment products. The services for platforms segment is also expected to grow as there is a rising trend of outsourcing sequencing services to specialized service providers.
- On the basis of technology, the market can be bifurcated into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. Among these, SBS technology currently dominates the market due to its accuracy, speed, and cost-effectiveness. However, nanopore sequencing is gaining traction due to its ability to sequence long reads in real-time, offering advantages in various applications such as structural variant detection and epigenetic analysis.
- In terms of application, the next-generation sequencing market is segmented into diagnostics, drug discovery, agriculture and animal research, precision medicine, and other applications. The diagnostics segment holds a significant share of the market as NGS technology enables the identification of genetic variations associated with various diseases, thereby aiding in personalized treatment strategies. The drug discovery segment is also growing rapidly, driven by the need for targeted therapies and precision medicine approaches.

**Market Players**

- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies
- Qiagen
- F. Hoffmann-La Roche Ltd
- BGI Group
- PerkinElmer Inc.
- Agilent Technologies, Inc.
- Eurofins Scientific

The global next-generation sequencing market is highly competitive, with key players focusing on strategic initiatives such as partnerships, collaborations, acquisitions, andThe next-generation sequencing (NGS) market has witnessed significant growth and is expected to continue expanding due to the increasing demands for advanced sequencing technologies across various industries. One key segment driving this market is the pre-sequencing products and services, which include sample and library preparation products as well as target enrichment solutions. This segment is expected to see substantial growth as the need for efficient and high-quality sample processing continues to rise. Additionally, the services for platforms segment is projected to grow as more organizations opt to outsource their sequencing needs to specialized service providers, enabling them to access cutting-edge technologies without heavy investments in equipment and expertise.

In terms of technology, sequencing by synthesis (SBS) currently dominates the market due to its proven accuracy, speed, and cost-effectiveness. However, nanopore sequencing technology is gaining momentum with its ability to provide real-time long-read sequencing, offering advantages in applications such as structural variant detection and epigenetic analysis. As this technology matures and becomes more widely adopted, it is expected to drive further innovation and growth within the NGS market.

The applications of NGS technology span across various industries, with diagnostics and drug discovery being key segments driving market growth. The diagnostics segment benefits significantly from NGS technology's ability to identify genetic variations associated with diseases, enabling personalized treatment strategies and improving patient outcomes. Similarly, the drug discovery segment is experiencing rapid expansion, driven by the increasing demand for targeted therapies and precision medicine approaches that leverage NGS technologies for informed decision-making.

Key players in the global NGS market include industry giants such as Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., and Oxford Nanopore Technologies, among others. These market leaders are focusing on strategic initiatives such as partnerships, collaborations, and acquisitions to expand their product portfolios, enhance technological capabilities, and capture a larger market share. Additionally, advancements in bioinformatics tools and data analysis solutions are essential for maximizing the value of NGS technologies, and companies are investingThe next-generation sequencing (NGS) market has been witnessing significant growth due to the increasing demand for advanced sequencing technologies across various industries. One of the key segments propelling this market forward is the pre-sequencing products and services segment, encompassing sample preparation, library preparation, and target enrichment solutions. This segment is expected to experience substantial growth as the need for efficient and high-quality sample processing continues to rise. Moreover, the services for platforms segment is projected to expand as more organizations choose to outsource their sequencing requirements to specialized service providers, enabling them to access cutting-edge technologies without extensive investments in equipment and expertise.

In terms of technology, sequencing by synthesis (SBS) presently dominates the market due to its established accuracy, speed, and cost-effectiveness. However, nanopore sequencing technology is gaining momentum due to its real-time long-read sequencing capabilities, offering advantages in applications such as structural variant detection and epigenetic analysis. As nanopore sequencing technology matures and gains wider adoption, it is likely to drive further innovation and growth within the NGS market, potentially impacting the market dynamics and competitive landscape.

The applications of NGS technology span various sectors, with diagnostics and drug discovery emerging as key segments fueling market growth. The diagnostics segment particularly benefits from NGS technology's capacity to identify genetic variations associated with diseases, facilitating personalized treatment strategies and enhancing patient outcomes. Similarly, the drug discovery segment is rapidly expanding, driven by the escalating demand for targeted therapies and precision medicine approaches that leverage NGS

Explore Further Details about This Research Next Generation Sequencing (NGS) Market Report https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market

Key Benefits for Industry Participants and Stakeholders: –

Industry drivers, trends, restraints, and opportunities are covered in the study.
Neutral perspective on the Next Generation Sequencing (NGS) Market scenario
Recent industry growth and new developments
Competitive landscape and strategies of key companies
The Historical, current, and estimated Next Generation Sequencing (NGS) Market size in terms of value and size
In-depth, comprehensive analysis and forecasting of the Next Generation Sequencing (NGS) Market

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2031) of the following regions are covered in Chapters

The countries covered in the Next Generation Sequencing (NGS) Market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of the Middle East and Africa

Detailed TOC of Next Generation Sequencing (NGS) Market Insights and Forecast to 2031

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Next Generation Sequencing (NGS) Market Landscape

Part 05: Pipeline Analysis

Part 06: Next Generation Sequencing (NGS) Market Sizing

Part 07: Five Forces Analysis

Part 08: Next Generation Sequencing (NGS) Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Next Generation Sequencing (NGS) Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse More Reports:

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 978

Email:- [email protected]

Next_Generation_Sequencing_(NGS)

Please log in to like, share and comment!